These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19029443)

  • 1. Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.
    Veljkovic DK; Rivard GE; Diamandis M; Blavignac J; Cramer-Bordé EM; Hayward CP
    Blood; 2009 Feb; 113(7):1535-42. PubMed ID: 19029443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes.
    Diamandis M; Paterson AD; Rommens JM; Veljkovic DK; Blavignac J; Bulman DE; Waye JS; Derome F; Rivard GE; Hayward CP
    Blood; 2009 Feb; 113(7):1543-6. PubMed ID: 18988861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.
    Kahr WH; Zheng S; Sheth PM; Pai M; Cowie A; Bouchard M; Podor TJ; Rivard GE; Hayward CP
    Blood; 2001 Jul; 98(2):257-65. PubMed ID: 11435291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes.
    Hayward CP; Liang M; Tasneem S; Soomro A; Waye JS; Paterson AD; Rivard GE; Wilson MD
    PLoS One; 2017; 12(3):e0173991. PubMed ID: 28301587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder.
    Sheth PM; Kahr WH; Haq MA; Veljkovic DK; Rivard GE; Hayward CP
    Thromb Haemost; 2003 Aug; 90(2):293-8. PubMed ID: 12888877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quebec platelet disorder: features, pathogenesis and treatment.
    Diamandis M; Veljkovic DK; Maurer-Spurej E; Rivard GE; Hayward CP
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):109-19. PubMed ID: 18277131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment.
    Blavignac J; Bunimov N; Rivard GE; Hayward CP
    Semin Thromb Hemost; 2011 Sep; 37(6):713-20. PubMed ID: 22102275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis.
    Diamandis M; Adam F; Kahr WH; Wang P; Chorneyko KA; Arsenault AL; Rivard GE; Hayward CP
    J Thromb Haemost; 2006 May; 4(5):1086-94. PubMed ID: 16689763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quebec platelet disorder.
    Hayward CP; Rivard GE
    Expert Rev Hematol; 2011 Apr; 4(2):137-41. PubMed ID: 21495923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene.
    Paterson AD; Rommens JM; Bharaj B; Blavignac J; Wong I; Diamandis M; Waye JS; Rivard GE; Hayward CP
    Blood; 2010 Feb; 115(6):1264-6. PubMed ID: 20007542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Packaging of supplemented urokinase into alpha granules of in vitro-grown megakaryocytes for targeted nascent clot lysis.
    Poncz M; Zaitsev SV; Ahn H; Kowalska MA; Bdeir K; Dergilev KV; Ivanciu L; Camire RM; Cines DB; Stepanova V
    Blood Adv; 2024 Jul; 8(14):3798-3809. PubMed ID: 38805575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancer-gene rewiring in the pathogenesis of Quebec platelet disorder.
    Liang M; Soomro A; Tasneem S; Abatti LE; Alizada A; Yuan X; Uusküla-Reimand L; Antounians L; Alvi SA; Paterson AD; Rivard GÉ; Scott IC; Mitchell JA; Hayward CPM; Wilson MD
    Blood; 2020 Dec; 136(23):2679-2690. PubMed ID: 32663239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin generation abnormalities in Quebec platelet disorder.
    Brunet JG; Sharma T; Tasneem S; Liang M; Wilson MD; Rivard GE; Hayward CPM
    Int J Lab Hematol; 2020 Dec; 42(6):801-809. PubMed ID: 32761872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated platelets increase fibrinolysis of mesenchymal progenitor cells.
    Agis H; Kandler B; Fischer MB; Watzek G; Gruber R
    J Orthop Res; 2009 Jul; 27(7):972-80. PubMed ID: 19030175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited disorders of the fibrinolytic pathway.
    Jain S; Acharya SS
    Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Packaging of supplemented urokinase into naked alpha-granules of
    Poncz M; Zaitsev SV; Ahn H; Kowalska MA; Bdeir K; Camire RM; Cines DB; Stepanova V
    bioRxiv; 2023 Dec; ():. PubMed ID: 38106191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling mechanisms that control platelet production.
    Italiano JE
    Semin Thromb Hemost; 2013 Feb; 39(1):15-24. PubMed ID: 23266965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The urokinase-receptor (CD87) is expressed in cells of the megakaryoblastic lineage.
    Wohn KD; Kanse SM; Deutsch V; Schmidt T; Eldor A; Preissner KT
    Thromb Haemost; 1997 Mar; 77(3):540-7. PubMed ID: 9066008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Megakaryocytes and platelets in alpha-granule disorders.
    Smith MP; Cramer EM; Savidge GF
    Baillieres Clin Haematol; 1997 Feb; 10(1):125-48. PubMed ID: 9154319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
    Wells JM; Strickland S
    J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.